Prostate Cancer Foundation is located in Santa Monica, CA. The organization was established in 1993. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 12/2021, Prostate Cancer Foundation employed 41 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Prostate Cancer Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Prostate Cancer Foundation generated $53.0m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 3.9% each year. All expenses for the organization totaled $41.7m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Prostate Cancer Foundation has awarded 70 individual grants totaling $41,232,607. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE PROSTATE CANCER FOUNDATION IS THE WORLD'S LEADING PHILANTHROPIC ORGANIZATION FUNDING AND ACCELERATING PROSTATE CANCER RESEARCH. SINCE 1993, PCF'S INNOVATIVE RESEARCH HAS HELPED PATIENTS AROUND THE WORLD LIVE LONGER, SUFFER FEWER COMPLICATIONS, AND ENJOY BETTER QUALITY OF LIFE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE PCF RESEARCH ENTERPRISE IS A PEER-REVIEW RESEARCH FUNDING PROGRAM THAT PROVIDES FUNDING TO 2601 SCIENTISTS CONDUCTING INNOVATIVE RESEARCH PROJECTS AT MORE THAN 236 LEADING CANCER CENTERS AND UNIVERSITIES. PRIORITY IS GIVEN TO HIGH-RISK, HIGH-RETURN PROJECTS WITH THE GREATEST POTENTIAL TO IMPROVE SURVIVAL AND THE OVERALL QUALITY OF LIFE FOR MEN WITH PROSTATE CANCER. THE CORNERSTONE OF THE PCF RESEARCH ENTERPRISE IN 2021 WAS OUR CHALLENGE AWARDS PROGRAM. PCF CHALLENGE AWARDS SUPPORT CROSS-DISCIPLINARY TEAMS OF INVESTIGATORS CONDUCTING PIONEERING RESEARCH TO ADDRESS CRITICAL UNMET MEDICAL NEEDS FOR PROSTATE CANCER PATIENTS. IN 2021, PCF FUNDED 12 MULTI-YEAR TEAM RESEARCH PROJECTS THAT EACH OFFER HIGH POTENTIAL FOR IMPROVED DETECTION, ENHANCED QUALITY OF LIFE AND HIGHER SURVIVAL RATES. ALL PCF-FUNDED RESEARCHERS ARE REQUIRED TO OPENLY SHARE THEIR UNPUBLISHED FINDINGS ON AN ANNUAL BASIS WITH THE ENTIRE GLOBAL RESEARCH COMMUNITY OF PCF AWARD RECIPIENTS. SEE SCHEDULE O FOR MORE INFORMATION.
MORE THAN 12,000 MEN CARED FOR BY THE DEPARTMENT OF VETERANS AFFAIRS (VA) HOSPITALS ARE NEWLY DIAGNOSED WITH PROSTATE CANCER EACH YEAR, MAKING IT THE MOST FREQUENTLY DIAGNOSED CANCER AMONG VETERANS. THE PCF-VA PARTNERSHIP IS EXPANDING RESEARCH INTO PROSTATE CANCER PRECISION ONCOLOGY TREATMENT OPTIONS. THE COLLABORATION IS EXPANDING THE NUMBER OF PRECISION ONCOLOGY CLINICAL STUDIES CONDUCTED AT VETERANS HEALTH ADMINISTRATION HOSPITALS, ENSURING THAT ELIGIBLE VETERANS CAN ACCESS AND PARTICIPATE IN THESE STUDIES. IN 2021, PCF'S DEDICATED NETWORK OF CENTERS OF EXCELLENCE (COE) EXECUTED THE AMBITIOUS MISSION OF IMPROVING THE CARE FOR THOUSANDS OF U.S. VETERANS WITH PROSTATE CANCER. THESE CENTERS ARE LOCATED IN PORTLAND, OR, SAN FRANCISCO, CA, PHILADELPHIA, PA, WASHINGTON, DC, DURHAM, NC, TAMPA BAY, FL, SEATTLE, WA, CHICAGO, IL, BRONX, NY, LOS ANGELES, CA, MANHATTAN, NY, ANN ARBOR, MI, ATLANTA, GA, AND BALTIMORE, MD. PCF'S VETERANS HEALTH INITIATIVE WAS FOUNDED IN 2016 AS PART OF THE CANCER MOONSHOT TO ENSURE VETERANS, WHO DESERVE THE VERY BEST FROM OUR COUNTRY, RECEIVE THE VERY BEST RESEARCH AND PRECISION ONCOLOGY CARE FOR PROSTATE CANCER AVAILABLE THROUGH THE PCF-VA NETWORK.FOR MORE THAN 3 MILLION AMERICAN MEN AND THEIR FAMILIES FIGHTING PROSTATE CANCER AND MILLIONS MORE GLOBALLY, PCF IS A PRIMARY SOURCE FOR NEW STANDARD-OF-CARE AND RESEARCH INFORMATION. PCF EDUCATES THE PUBLIC ABOUT PROSTATE CANCER RISKS, SCREENING, PREVENTION, TREATMENT OPTIONS, AND SIDE EFFECTS. WE CONNECT PATIENTS, LOVED ONES, CARE PROVIDERS AND SCIENTISTS TO CRITICAL UPDATES, THE LATEST DEVELOPMENTS, BEST PRACTICES, AND NEWS FROM THE TREATMENT PIPELINE.
PCF CREATED THE YOUNG INVESTIGATOR AWARD PROGRAM WITH ONE GOAL: TO BUILD A GIFTED COHORT OF HUMAN CAPITAL SUPPORTING THE NEXT GENERATION OF PROSTATE CANCER RESEARCHERS. AWARDS ARE MADE TO EARLY-CAREER SCIENTISTS WORKING IN A RESEARCH ENVIRONMENT CAPABLE OF SUPPORTING HIGH-IMPACT PROSTATE CANCER RESEARCH, DRAWN FROM A VARIETY OF MEDICAL RESEARCH DISCIPLINES. THE AWARD FUNDS MAY BE USED FLEXIBLY TO ADVANCE THE CAREER AND RESEARCH EFFORTS OF THE AWARDEE. MENTORSHIP IS REQUIRED FOR EVERY PCF YOUNG INVESTIGATOR. SINCE 2007, PCF HAS AWARDED MORE THAN $65 MILLION TO ADVANCE THE EARLY CAREERS OF 349 PCF YOUNG INVESTIGATORS, ENSURING A CONTINUED STREAM OF HUMAN CAPITAL INTO OUR RESEARCH COMMUNITY. MANY HAVE BECOME MAJOR RESEARCH PROGRAM LEADERS. THE PCF YOUNG INVESTIGATOR PROGRAM PLAYS AN INTEGRAL ROLE IN CHAMPIONING, MENTORING, AND IDENTIFYING STRONG LEADERSHIP POTENTIAL IN EARLY-CAREER HUMAN CAPITAL INVESTMENTS.
FOR MORE THAN 3 MILLION AMERICAN MEN AND THEIR FAMILIES FIGHTING PROSTATE CANCER AND MILLIONS MORE GLOBALLY, PCF IS A PRIMARY SOURCE FOR NEW STANDARD-OF-CARE AND RESEARCH INFORMATION. PCF EDUCATES THE PUBLIC ABOUT PROSTATE CANCER RISKS, SCREENING, PREVENTION, TREATMENT OPTIONS, AND SIDE EFFECTS. WE CONNECT PATIENTS, LOVED ONES, CARE PROVIDERS AND SCIENTISTS TO CRITICAL UPDATES, THE LATEST DEVELOPMENTS, BEST PRACTICES, AND NEWS FROM THE TREATMENT PIPELINE. SINCE PCF'S INCEPTION, AND THROUGH ITS EFFORTS, PATIENTS AROUND THE WORLD ARE LIVING LONGER, SUFFERING FEWER COMPLICATIONS, AND ENJOYING BETTER QUALITY OF LIFE. PCF IS COMMITTED TO CREATING A GLOBAL PUBLIC SQUARE FOR PROSTATE CANCER, IN SERVICE TO OUR MISSION OF ENDING DEATH AND SUFFERING FROM THE DISEASE. THROUGH YEAR-ROUND AWARENESS AND EDUCATION PROGRAMS, PCF AIMS TO SPUR MEN AND WOMEN ALIKE TO TALK ABOUT THIS DISEASE, TO UNDERSTAND ITS URGENCY, AND TO HAVE INFORMATION-DRIVEN HOPE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jonathan W Simons MD CEO & President (left 8/21) | OfficerTrustee | 60 | $947,055 |
Howard Soule Evp, Chief Science Officer | Officer | 50 | $489,783 |
Christine Jones Chief Operating Officer | Officer | 50 | $387,030 |
Charles Ryan Joined 1021 CEO & President | OfficerTrustee | 60 | $298,805 |
Helen Hsieh Svp, Finance & Administration | 50 | $295,799 | |
Stuart Holden MD Director/medical Director | Trustee | 30 | $225,000 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Vision Matrix Productions Inc Event Productions | 12/30/21 | $227,762 |
Boulle Event Management Outreach Program Mgmt. | 12/30/21 | $180,000 |
Dave Perron Consulting | 12/30/21 | $123,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $3,634,762 |
Related organizations | $0 |
Government grants | $895,750 |
All other contributions, gifts, grants, and similar amounts not included above | $48,467,107 |
Noncash contributions included in lines 1a–1f | $1,088,346 |
Total Revenue from Contributions, Gifts, Grants & Similar | $52,997,619 |
Total Program Service Revenue | $4,617 |
Investment income | $14,834 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$320 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $53,016,750 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $22,434,297 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $3,996,485 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $2,479,318 |
Compensation of current officers, directors, key employees. | $172,663 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,982,652 |
Pension plan accruals and contributions | $115,673 |
Other employee benefits | $407,366 |
Payroll taxes | $356,439 |
Fees for services: Management | $715,591 |
Fees for services: Legal | $103,790 |
Fees for services: Accounting | $53,859 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $1,775 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $501,965 |
Advertising and promotion | $530,891 |
Office expenses | $871,664 |
Information technology | $735,614 |
Royalties | $0 |
Occupancy | $649,907 |
Travel | $368,500 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $3,894,386 |
Interest | $78 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $165,820 |
Insurance | $113,429 |
All other expenses | $20,488 |
Total functional expenses | $41,671,787 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,000 |
Savings and temporary cash investments | $38,558,032 |
Pledges and grants receivable | $19,610,715 |
Accounts receivable, net | $9,591 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $170,267 |
Net Land, buildings, and equipment | $768,268 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $3,375,000 |
Other assets | $50,000 |
Total assets | $62,542,873 |
Accounts payable and accrued expenses | $2,430,391 |
Grants payable | $23,229,447 |
Deferred revenue | $50,000 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $2,531,250 |
Other liabilities | $0 |
Total liabilities | $28,241,088 |
Net assets without donor restrictions | $17,078,257 |
Net assets with donor restrictions | $17,223,528 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $62,542,873 |
Over the last fiscal year, Prostate Cancer Foundation has awarded $22,434,297 in support to 37 organizations.
Grant Recipient | Amount |
---|---|
Baltimore, MD PURPOSE: CANCER RESEARCH | $4,300,907 |
San Francisco, CA PURPOSE: CANCER RESEARCH | $2,250,000 |
Philadelphia, PA PURPOSE: CANCER RESEARCH | $1,253,600 |
WEILL CORNELL MEDICAL COLLEGE PURPOSE: CANCER RESEARCH | $1,120,000 |
Chapel Hill, NC PURPOSE: CANCER RESEARCH | $1,000,000 |
Boston, MA PURPOSE: CANCER RESEARCH | $975,000 |
Over the last fiscal year, we have identified 15 grants that Prostate Cancer Foundation has recieved totaling $85,475.
Awarding Organization | Amount |
---|---|
Mickey Shapiro Charitable Tr Farmington Hills, MI PURPOSE: CHARITABLE WITHOUT RESTRICTIONS | $25,000 |
Gray Foundation Cohoes, NY PURPOSE: TO FURTHER THE EXEMPT PURPOSE OF THE ORGANIZATION. | $25,000 |
Dauber Foundation Cupertino, CA PURPOSE: UNRESTRICTED | $10,000 |
Sullivan Family Foundation Eden, NY PURPOSE: CHARITABLE | $10,000 |
The Hwang Foundation Wilmington, DE PURPOSE: GENERAL & UNRESTRICTED | $7,075 |
Patsy And Michael Hochman Charitable Foundation Dallas, TX PURPOSE: PROGRAM SUPPORT | $5,000 |
Organization Name | Assets | Revenue |
---|---|---|
Koum Family Foundation Palo Alto, CA | $2,010,566,070 | $59,411,015 |
The David Geffen Foundation Los Angeles, CA | $481,191,890 | $36,420,193 |
Knight Foundation Beaverton, OR | $3,232,383,420 | $1,963,443,063 |
Waverley Street Foundation Palo Alto, CA | $2,988,003,660 | $1,311,729,919 |
Dr Miriam And Sheldon G Adelson Las Vegas, NV | $37,664,470 | $5,516,038 |
Shimon Ben Joseph Foundation San Francisco, CA | $1,592,283,787 | $39,921,005 |
Alfred C Munger Foundation Los Angeles, CA | $17,737,694 | $91,163,030 |
Hellman Foundation San Francisco, CA | $693,471,633 | $133,789,010 |
The Eric And Wendy Schmidt Fund For Strategic Innovation Palo Alto, CA | $1,715,568,763 | $412,161,407 |
Omidyar Network Fund Inc Redwood City, CA | $490,038,780 | $21,031,743 |
Sobrato Family Foundation Mountain View, CA | $811,956,453 | $266,068,436 |
Moore Family Foundation Incline Village, NV | $173,909 | $5,659,701 |